美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
40498 A II 2024/10/11 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD TEDIZOLID PHOSPHATE
40507 A IV 2024/10/11 XIAMEN SINOPEG BIOTECH CO LTD FMOC-LYS(TBUO-ARA-GLU(AEEA-AEEA)-OTBU)-OH
40551 A II 2024/10/11 CELLUPRO LTD SFM001 MEDIUM
39618 A IV 2024/10/10 CIPLA LTD SALCAPROZATE SODIUM
40393 I II 2024/10/10 CHANGZHOU SYNTHEALL PHARMACEUTICAL CO LTD 2'-OME G(IBU) AMIDITE
40394 I II 2024/10/10 CHANGZHOU SYNTHEALL PHARMACEUTICAL CO LTD 2' -OME C(AC) AMIDITE
40395 I II 2024/10/10 CHANGZHOU SYNTHEALL PHARMACEUTICAL CO LTD 2'-OME A(BZ) AMIDITE
40396 I II 2024/10/10 CHANGZHOU SYNTHEALL PHARMACEUTICAL CO LTD 2'-OME U AMIDITE
40522 A II 2024/10/10 SARTORIUS STEDIM BIOTECH GMBH 4CELL XTRACHO MEDIA SYSTEM
40628 A II 2024/10/10 BIOPHORE INDIA PHARMACEUTICALS PVT LTD TOLVAPTAN AMORPHOUS
37638 A II 2024/10/10 AGNO PHARMA INDOMETHACIN USP
40610 A II 2024/10/09 EMNAR PHARMA PRIVATE LTD PRIDINOL MESILATE
40294 A II 2024/10/09 AVANTI POLAR LIPIDS N-DODECYL-ß-D-MALTOSIDE) (DDM) (770520)
40375 A II 2024/10/08 MEGAFINE PHARMA P LTD LURASIDONE HYDROCHLORIDE
40603 A II 2024/10/08 SHENZHEN HAIBIN PHARMACEUTICAL CO LTD OSELTAMIVIR PHOSPHATE
40332 A II 2024/10/07 HONOUR LAB LTD EMPAGLIFLOZIN (PROCESS-II)
40643 A II 2024/10/07 AMI LIFESCIENCES PRIVATE LTD TEGOPRAZAN (CRYSTALLINE)
40012 A II 2024/10/07 INDENA SPA TIRBANIBULIN
40484 A II 2024/10/06 LEADGENE BIOMEDICAL INC RECOMBINANT PROTEIN (LGX-23001; LDG002/003PHE-GMP; LDG009PHE-GMP; LDG013/014PHE-GMP)
40601 A II 2024/10/05 SHODHANA LABORATORIES PRIVATE LTD RIVASTIGMINE

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files